Fukuda Koji, Miura Yasushi, Maeda Toshihisa, Hayashi Shinya, Kurosaka Masahiro
Department of Orthopaedic Surgery, Kobe University Graduate School of Medicine, Kobe 650‑0017, Japan.
Mol Med Rep. 2016 Apr;13(4):3647-52. doi: 10.3892/mmr.2016.4985. Epub 2016 Mar 7.
Decoy receptor 3 (DcR3) competitively binds to three ligands, Fas ligand, lymphotoxin‑related inducible ligand that competes for glycoprotein D binding to herpesvirus entry mediator on T cells and tumor necrosis factor‑like ligand 1A (TL1A), to prevent their effects. Recent studies have suggested that DcR3 directly affects cells as a ligand. Using a microarray assay, our group newly identified interleukin (IL)‑12B, which encodes the p40 subunit common to IL‑12 and IL‑23, as one of the genes for which expression in fibroblast‑like synoviocytes from patients with rheumatoid arthritis (RA‑FLS) is induced by DcR3. The present study demonstrated that IL‑12B mRNA expression was upregulated by DcR3‑Fc in RA‑FLS in a dose‑dependent manner, but not in OA‑FLS. IL‑12B p40 protein in RA‑FLS was increased when stimulated with DcR3‑Fc. Pre‑treatment with anti‑TL1A antibody suppressed the upregulation of IL‑12B mRNA in RA‑FLS stimulated with DcR3‑Fc. DcR3 mRNA expression in RA‑FLS was induced by IL‑23, but not by IL‑12. These results indicated that DcR3 may increase IL‑12 or IL‑23 by inducing IL‑12B p40 expression via membrane‑bound TL1A on RA‑FLS and that IL‑23 reciprocally induces DcR3 expression in RA‑FLS. DcR3 and IL‑23 may interact in a feedback loop that aggravates local inflammation in patients with RA.
诱饵受体3(DcR3)竞争性结合三种配体,即Fas配体、与淋巴细胞毒素相关的诱导配体(其可竞争糖蛋白D与T细胞上疱疹病毒进入介质的结合)以及肿瘤坏死因子样配体1A(TL1A),以阻止它们发挥作用。最近的研究表明,DcR3可作为一种配体直接影响细胞。通过微阵列分析,我们的研究小组新鉴定出白细胞介素(IL)-12B,其编码IL-12和IL-23共有的p40亚基,是类风湿性关节炎患者(RA-FLS)的成纤维样滑膜细胞中受DcR3诱导表达的基因之一。本研究表明,DcR3-Fc在RA-FLS中以剂量依赖性方式上调IL-12B mRNA表达,但在骨关节炎-FLS(OA-FLS)中则不然。用DcR3-Fc刺激时,RA-FLS中的IL-12B p40蛋白增加。用抗TL1A抗体预处理可抑制DcR3-Fc刺激的RA-FLS中IL-12B mRNA的上调。IL-23可诱导RA-FLS中DcR3 mRNA表达,但IL-12则不能。这些结果表明,DcR3可能通过RA-FLS上的膜结合TL1A诱导IL-12B p40表达,从而增加IL-12或IL-23,并且IL-23可相互诱导RA-FLS中DcR3表达。DcR3和IL-23可能在一个反馈回路中相互作用,加重RA患者的局部炎症。